<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Palatino;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.EmailStyle18
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal"><b><span style="color:#1F497D"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:red">REMINDER: Toffler Scholar Program applications are due MONDAY, NOVEMBER 9, 2020.</span><span style="font-size:12.0pt;font-family:Palatino;color:#1F497D"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:#1F497D"><a href="https://med.fsu.edu/researchdivision/toffler-scholar-program" target="_blank">Toffler Scholar Program<o:p></o:p></a></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Open to FSU researchers</span></b><span style="font-size:12.0pt;font-family:Palatino">. The Toffler Scholar Program was created by the Trustees of the Karen Toffler Charitable Trust,
a 501 C3 nonprofit foundation focused on early-stage research that advances the medical field in profound, high-impact ways. Tapping into the deep legacy of their founders, best-selling authors and futurists, Alvin and Heidi Toffler, the trust exists to be
a catalyst for future – focused breakthroughs. The Toffler Scholar Program focuses on helping university medical researchers gain access to support, and a network for often underfunded innovations. It is a nimble source of financial support for medical researchers
working on <b>early-stage, future-focused brain science</b>. Together with the FSU College of Medicine, the program helps foster new ways of thinking and problem solving to find solutions to humanity’s most difficult problems. Toffler Scholar grants are one-year
grants that currently range from $20,000 - $30,000 per award.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due November 9, 2020.</span></b><span style="font-size:12.0pt;font-family:Palatino">
<b><span style="color:red">Med-RA draft review is not required.</span></b><span style="color:#1F497D"><o:p></o:p></span></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://dtrf.org/wp-content/uploads/2020/03/Dec-2020-General-RFP.pdf__;!!PhOWcWs!igenTu2Mfk8DqrwmV6SHXub15u-mLVVqCe1U8-adHEvRv0_zAKXRZkeyDlTwuOCdphMt1Fb3BQvmNK6d6o0$" target="_blank">Desmoid Tumor Research</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">The Desmoid Tumor Research Foundation welcomes applications for its research grant program. Through the program, grants of up to $65,000 will be awarded for research that advances current
scientific knowledge of desmoid tumors using science and creative clinical applications, as well as novel approaches that addresses potential leads based on prior research. Proposals with additional sources of funding support are particularly desirable, and
researchers must be willing to collaborate with other scientists and institutions with similar interests. Grantees must agree to participate as reviewers in DTRF’s future grant review cycle and present the results of their research at the annual September
International DTRF Desmoid Tumor Research Workshop.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due December 1, 2020.
<span style="color:red">Med-RA deadline to receive draft documents: November 16 (due to Thanksgiving break).<o:p></o:p></span></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://www.lung.org/getmedia/86b126cf-2311-4c5e-9bbe-8996c246c03f/2021-innovation-award-rfp-and-app-guide.pdf__;!!PhOWcWs!igenTu2Mfk8DqrwmV6SHXub15u-mLVVqCe1U8-adHEvRv0_zAKXRZkeyDlTwuOCdphMt1Fb3BQvmXlIxSmo$" target="_blank">American Lung Association: Innovation Awards</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">The American Lung Association works to fight lung disease by advancing treatment and unlocking the secrets of the body’s immune system, including breakthroughs in the fight against tuberculosis,
identifying the genes that cause the development of lung cancer and cystic fibrosis, and developing innovative ways to treat respiratory distress syndrome. To help advance this mission, ALA is inviting applications for its Innovation Award program. Through
the program, grants of up to $75,000 a year for up to two years will be awarded in support of highly promising investigators with stellar track records of accomplishment and the potential to advance the field of lung disease science. Note: Applicants must
have held a K or R type award within three years prior to applying for this award.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due December 10, 2020.
<span style="color:red">Med-RA deadline to receive draft documents: November 30.</span><o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://milkeninstitute.org/sites/default/files/2020-10/v22021*20Misophonia*20Research*20Fund*20RFP.pdf__;JSUlJQ!!PhOWcWs!igenTu2Mfk8DqrwmV6SHXub15u-mLVVqCe1U8-adHEvRv0_zAKXRZkeyDlTwuOCdphMt1Fb3BQvmrIx8vxU$" target="_blank">Misophonia Research</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">Proposals must address one or more of the following three broad areas in human, animal, or relevant research models: 1) research focused on characterizing misophonia, including exploring
its underlying mechanisms, expression, natural history, and/or development; 2) development of diagnostic tools to facilitate rapid, physiologically-relevant assessment; 3) clinical and/or model studies of specific interventions, including studies investigating
comparative effectiveness, novel treatments, and controlled trials of promising treatments<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">The program supports two-year projects led by either faculty members or postdocs with annual budgets of up to $200,000.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Letter of intent due December 11, 2020.
<span style="color:red">Med-RA deadline to receive draft documents: November 30.</span><o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-008.html__;!!PhOWcWs!igenTu2Mfk8DqrwmV6SHXub15u-mLVVqCe1U8-adHEvRv0_zAKXRZkeyDlTwuOCdphMt1Fb3BQvmotL4bqE$" target="_blank">Treatments for Lewy Body Dementias–Exploratory Clinical Trial (U01 Clinical Trial Required)</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">This Funding Opportunity Announcement invites applications from investigators seeking to conduct exploratory clinical trials designed to test new treatments for patients with Lewy Body
Dementia (LBD). Applicants may propose to conduct either Phase I or Phase II clinical trials depending on the developmental stage of the potential therapeutic, but all trials must include patients with LBD. Proposed therapies may include novel medications
or devices, or existing treatments that are potentially beneficial but not currently approved for use in patients with LBD. Treatments intended to prevent or delay disease progression in LBD patients, as well as therapies to alleviate existing motor or non-motor
clinical symptoms, are of interest.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due March 2, 2020.
<span style="color:red">Med-RA deadline to receive draft documents: February 17.<o:p></o:p></span></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:red"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">To search for additional funding opportunities, please visit </span></b><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__fsucomgrants.wordpress.com_&d=DwMGaQ&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=-WQkPIXZLCgXlX-d14DY8B-SG-GvP9FZHr_Gv8sUuTQ&s=ErAzzubGxiJsWCKGnlFjfXV6980C-DCl-AxzFLHMVYQ&e=" title="https://urldefense.proofpoint.com/v2/url?u=https-3A__fsucomgrants.wordpress.com_&d=DwMGaQ&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=-WQkPIXZLCgXlX-d14DY8B-SG-GvP9FZHr_Gv8sUuTQ&s=ErAzzubGxiJsWCKGnlFjfXV69"><b>CoM’s
unofficial funding opportunities blog</b></a><b>.</b><o:p></o:p></span></p>
</div>
</body>
</html>